BA
NVRO

Broadview Advisors’s NEVRO CORP. NVRO Stock Holding History

Broadview Advisors’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$2.06M Sell
31,850
-575
-2% -$35.8K 0.64% 52
2019
Q1 		$2.03M Sell
32,425
-18,975
-37% -$892K 0.55% 60
2018
Q4 		$2M Buy
+51,400
New +$2.28M 0.58% 55

Other funds holding NVRO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Broadview Advisors's NVRO Position: Q2 2019 in Review

Broadview Advisors reduced its NEVRO CORP. (NVRO) stake by 1.8% in Q2 2019, selling an estimated $35.8K and leaving 31,850 shares worth $2.06M. The position accounts for 0.64% of the portfolio, ranked #52.

Broadview Advisors first reported a position in NVRO in Q4 2018 and has held it in 3 quarters since. 162 funds tracked by Wall St. Rank hold NVRO as of Q2 2019.

  • Broadview Advisors held 31,850 shares of NEVRO CORP. worth $2.06M as of Q2 2019.
  • Broadview Advisors sold 575 NEVRO CORP. shares in Q2 2019, an estimated $35.8K.
  • NEVRO CORP. made up 0.64% of Broadview Advisors's portfolio in Q2 2019, its #52 holding.
  • Broadview Advisors first reported a position in NEVRO CORP. in Q4 2018 and has held it in 3 quarters since.
  • 162 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2019.

Based on Broadview Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.